Fundamentals of reperfusion injury for the clinical cardiologist

Circulation

Volumn 105, Issue 20, 2002, Pages 2332-2336

  Verma, Subodh ^a   Fedak, Paul W M ^a   Weisel, Richard D ^a,b   Butany, Jagdish ^a   Rao, Vivek ^a   Maitland, Andrew ^a   Li, Ren Ke ^a   Dhillon, Bikramjit ^a   Yau, Terrence M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ANTIOXIDANT; CALCIUM; INOTROPIC AGENT; INSULIN; OXYGEN RADICAL; SODIUM PROTON EXCHANGE PROTEIN;

CARDIOLOGY; CARDIOVASCULAR RISK; CLINICAL FEATURE; ENDOTHELIUM; HEART MUSCLE METABOLISM; HUMAN; MICROVASCULATURE; PATHOGENESIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RISK FACTOR;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CARDIOLOGY; CARDIOTONIC AGENTS; CLINICAL MEDICINE; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; FATAL OUTCOME; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIAL STUNNING; RISK FACTORS; THROMBOLYTIC THERAPY;

EID: 0037150155     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000016602.96363.36     Document Type: Review

References (33)

1. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part I
2. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part II
3. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: Distant dream or near reality?
4. Reperfusion injury: Experimental evidence and clinical implications
5. Evidence for stunned myocardium in humans: A 2001 update
6. Clinical manifestations of myocardial stunning
7. The stunned myocardium: Prolonged, postischemic ventricular dysfunction
8. Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs
9. Ischemia-reperfusion: Mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease
10. Mechanisms of myocardial reperfusion injury
11. Microvascular integrity after reperfusion therapy
12. Myocardial perfusion and oxygen consumption in reperfused noninfarcted dysfunctional myocardium after unstable angina: Direct evidence for myocardial stunning in humans
13. Medical and cellular implications of stunning, hibernation, and preconditioning: An NHLBI workshop
14. Prolonged impairment of regional contractile function after resolution of exercise-induced angina: Evidence of myocardial stunning in patients with coronary artery disease
15. Myocardial stunning after coronary bypass surgery
16. Mechanisms of postischemic contractile dysfunction
17. The role of neutrophils in myocardial ischemia-reperfusion injury
18. Pathophysiology of ischaemia-reperfusion injury
19. Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog
20. 2+-dependent proteolysis?
21. Role of troponin I proteolysis in the pathogenesis of stunned myocardium
22. Lactate release during reperfusion predicts low cardiac output syndrome after coronary bypass surgery
23. Myocardial aerobic metabolism is impaired in a cell culture model of cyanotic heart disease
24. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia
25. Insulin cardioplegia for elective coronary bypass surgery
26. Pharmacologic treatment of the stunned myocardium: The concepts and the challenges
27. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction
28. Mechanisms of protection of the ischemic and reperfused myocardium by sodium-hydrogen exchange inhibition
29. Inhibition of the sodium-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations: Main results of the GUARDIAN trial
30. Broad-spectrum cardioprotection with adenosine
31. Adenosine myocardial protection: Preliminary, results of a phase II clinical trial
32. Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury
33. L-arginine protects human heart cells from low-volume anoxia and reoxygenation